NEUROGENE
(NASDAQ: NGNE)
Neurogene, Inc. is a clinical-stage biotechnology company, which engages in the development of product portfolio of genetic medicines for rare neurological diseases. The company was founded in May 2007 and is headquartered in New York, NY.
45.570
+1.560
(+3.54%)
Range
44.647 - 45.660
(2.27%)
Open
44.730
Previous Close
44.010
Bid Price
-
Bid Volume
-
Ask Price
-
Ask Volume
-
Volume
11,321
Value
-
Remark
Delayed prices. Updated at 01 Nov 2024 22:38.
Data powered by
View All Events
Loading Chart...
Please login to view stock data and analysis
